|
LATEST NEWS
Approved supplemental prospectus26.02.2010 - Oslo Børs has approved following NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO Supplemental prospectus
> Read press relase
19.02.2010 - Approved Prospectus
|
Nutri5Nutri5® is a new product developed to be effective against menopausal and pre-menstrual symptoms.
By Dr. Lars H. Høie – FounderNutri Pharma is a company which has invested significant resources into R&D in the field of soy and nutrition to develop products
which help prevent lifestyle related disorders and improve the health and wellbeing of consumers.
|
R&DNutri Pharma has made considerable investments in developing patented products with proven health benefits, and our products
have been used in around 40 clinical and pre-clinical trials. On these pages you will find summaries and published documents
> Read more |
|
FINANCIAL CALENDAR
April 28, 2010
|
|